News - Page 161 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Tryp Therapeutics Announces Q3 2021 Financial Results

Tryp Therapeutics Announces Q3 2021 Financial Results

Post published:July 28, 2021
Post category:Press Release

Read more about the article MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT

MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT

Post published:July 28, 2021
Post category:Press Release

Read more about the article Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5

Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5

Post published:July 28, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP

Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP

Post published:July 27, 2021
Post category:Press Release

Read more about the article Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent

Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent

Post published:July 27, 2021
Post category:Press Release

Read more about the article MINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

MINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

Post published:July 27, 2021
Post category:Press Release

Read more about the article Awakn Life Sciences to Commence Trading on the OTC Market on July 26, 2021 Under the Symbol ‘AWKNF’

Awakn Life Sciences to Commence Trading on the OTC Market on July 26, 2021 Under the Symbol ‘AWKNF’

Post published:July 26, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor

Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor

Post published:July 26, 2021
Post category:Press Release

Read more about the article Psyched Wellness Enters into a Service Agreement with CannaLabs to Begin Stability Tests on AME-1

Psyched Wellness Enters into a Service Agreement with CannaLabs to Begin Stability Tests on AME-1

Post published:July 26, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Field Trip Set to List on Nasdaq; Cybin to List on NYSE American

Psychedelic Bulletin: Field Trip Set to List on Nasdaq; Cybin to List on NYSE American

Post published:July 24, 2021
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.